UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017636
Receipt number R000020374
Scientific Title Measurement of glycemic index (GI) of low-protein packed boiled rice as a potential candidate for controlling postprandial blood glucose elevation
Date of disclosure of the study information 2015/05/22
Last modified on 2016/12/27 16:13:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Measurement of glycemic index (GI) of low-protein packed boiled rice as a potential candidate for controlling postprandial blood glucose elevation

Acronym

Measurement of glycemic index (GI) of low-protein packed boiled rice as a potential candidate for controlling postprandial blood glucose elevation

Scientific Title

Measurement of glycemic index (GI) of low-protein packed boiled rice as a potential candidate for controlling postprandial blood glucose elevation

Scientific Title:Acronym

Measurement of glycemic index (GI) of low-protein packed boiled rice as a potential candidate for controlling postprandial blood glucose elevation

Region

Japan


Condition

Condition

No (subjects with fasting plasma glucose < 110mg/dl)

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Measurement of glycemic indexs(GI) of low-protein packed boiled rice, developed by proprietary technology consistiong of protein reduction of medium-amylose rice variety line "Yukihikari" followed by high temperature short time method cooking, in normal subjects

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Glycemic index(GI)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

placebo food

Interventions/Control_2

Rice-1

Interventions/Control_3

Rice-2

Interventions/Control_4

Rice-3

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Body mass index (BMI) = <30. 2.Fasting plasma glucose 70-110mg/dl 3.Volunteers being able to make self-judgent to particupate in this study and giving written informed consent. 4.Volunteers having screening test results judged to be appropriate for this study by investigator.

Key exclusion criteria

1.Volunteers having severe history of the diseases (liver,kidney,hert,blood) judged to be inappropriate for this study.
2.Volunteers received gastrectomy,enterectomy,and gastro-intestinal dedeases,judged to be inappropriate for this study.
3.Those of diabetes mellitus.
4.Volunteers rejected participating in this study by chief investigater.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name kenichi watanabe

Organization

Niigata Universty of Pharmacy and Applied Life Sciences

Division name

Laboratory of Clinical pharmacology

Zip code


Address

265-1, Higashijima, Akiha-ku, Niigata City

TEL

0250-25-5267

Email

watanabe@nupals.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Niigata Bio-Research Park, Inc

Organization

Niigata Bio-Research Park, Inc

Division name

Business promotion division

Zip code


Address

316-2 Higashijima, Akiha-ku, Niigata, 956-0811, Japan

TEL

0250-25-1196

Homepage URL


Email

goto@nbrp.co.jp


Sponsor or person

Institute

Niigata Bio-Research Park, Inc

Institute

Department

Personal name



Funding Source

Organization

Foricafoods Corporation.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 05 Month 21 Day

Date of IRB


Anticipated trial start date

2015 Year 05 Month 26 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 05 Month 20 Day

Last modified on

2016 Year 12 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020374


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name